Glaucoma Symptoms- A Silent Disease

Early Glaucoma Has No Symptoms. So How Do You Know You Have It? Dr Shibal Bhartiya explains who is at risk and how detecting glaucoma early saves vision. Late stage symptoms of glaucoma in adults include tunnel vision, difficulty navigating in low light, frequent collisions with objects in peripheral view, and eventually loss of central vision. But by the time these manifest, it is already late.

Most people expect a warning. A headacheBlurred vision. Some sign that something is wrong. With glaucoma, that warning rarely comes. Early glaucoma symptoms are almost always absent. By the time a patient notices something unusual, significant and irreversible nerve damage has already occurred. This is the central danger of glaucoma. It does not announce itself.

Understanding why early glaucoma has no symptoms, who is at risk, and how detection works is the most important thing any patient can do to protect their vision for life.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Clinical Reality (Glaucoma Symptoms — What’s Not Always Obvious)

  • Most glaucoma has no early symptoms
    Patients often expect pain, redness, or blurring — but early disease is typically silent.
  • Vision loss starts in the periphery, not the centre
    Patients retain reading vision while slowly losing side vision, so the problem goes unnoticed.
  • The brain compensates remarkably well
    Missing visual fields are “filled in,” delaying awareness of damage.
  • Symptoms appear late — when damage is irreversible
    By the time patients notice constricted vision, significant optic nerve loss has often already occurred.
  • Normal daily functioning gives false reassurance
    Driving, reading, and screen use may remain intact despite progressive field loss.
  • Acute symptoms are the exception, not the rule
    Sudden pain/redness occurs only in specific types like angle-closure glaucoma — not the common forms.

Why Early Glaucoma Has No Symptoms

The optic nerve carries visual information from your eye to your brain. Glaucoma damages this nerve slowly and silently. In the early stages, the brain compensates for the loss. It fills in gaps. It adjusts. The result is that early glaucoma symptoms go unnoticed even as nerve fibres die in significant numbers.

Peripheral vision is the first casualty. Central vision, the part you use to read and recognise faces, stays intact until late in the disease. Most people do not notice peripheral vision loss until 40% or more of their optic nerve is already damaged. By that point, the window for preventing serious disability has narrowed considerably.

This is why glaucoma no symptoms early is not a reassuring finding. It is a clinical trap.

Who Faces the Highest Glaucoma Risk Factors

Detecting glaucoma early depends on knowing who needs to be checked. Certain groups carry significantly higher glaucoma risk factors and must not wait for symptoms before seeking an eye examination.

Age is the single strongest risk factor. The risk of glaucoma rises sharply after 40 and continues to increase with each decade. A family history of glaucoma raises your personal risk by four to nine times. Indians carry a specific and underappreciated vulnerability. Primary angle closure glaucoma, a particularly aggressive form of the disease, is far more common in Indian eyes than in European populations. If you are Indian, over 40, and have never had your eye pressure and optic nerve checked, you are taking a risk you may not be aware of.

Elevated intraocular pressure is the most treatable glaucoma risk factor. High myopia, diabetes, a history of eye injury, prolonged steroid use, and thin corneas all increase risk further. None of these conditions cause early glaucoma symptoms that you would notice at home. All of them are detectable on clinical examination.

What Symptoms of Glaucoma in Adults Actually Look Like

In most cases, symptoms of glaucoma in adults do not exist in the early and middle stages. The disease is symptom-free until it is advanced. This is the defining feature of open angle glaucoma, which accounts for the majority of cases.

The exception is acute angle closure glaucoma. This is a medical emergency. Patients experience sudden severe eye pain, headache, nausea, vomiting, and blurred vision with coloured haloes around lights. If you experience these symptoms, seek emergency care immediately. This is not the silent form of the disease. It is the rare form that does announce itself. And it demands same-day treatment.

For the vast majority of glaucoma patients, however, symptoms of glaucoma in adults only appear after substantial vision loss. Tunnel vision, difficulty navigating in dim light, and needing to turn the head to see things that should be in peripheral view are late signs. Waiting for these signs means waiting too long.

Can You Check Signs of Glaucoma Early at Home?

Patients often ask whether they can check signs of glaucoma early at home. The answer is limited but worth understanding. You cannot measure your own intraocular pressure accurately. You cannot examine your own optic nerve. You cannot reliably detect peripheral field defects through self-assessment.

What you can do is observe. Cover each eye alternately and check whether your central vision looks clear and undistorted. Notice whether you are bumping into things, misjudging kerbs, or struggling in low light. Ask yourself whether reading has become harder, or whether driving feels less certain than it once did. These observations are not symptoms of glaucoma at home in a diagnostic sense. But they are reasons to make an appointment.

The more important question is not what you can detect at home. It is whether you are attending regular eye examinations at the correct intervals for your age and risk profile.

Detecting Glaucoma Early: What Happens in the Clinic

Detecting glaucoma early requires a set of specific clinical tests. A routine vision check with a chart does not detect glaucoma. You need a comprehensive eye examination that includes measurement of intraocular pressure, examination of the optic nerve, assessment of the drainage angle, corneal thickness measurement, and a visual field test.

Optical coherence tomography, or OCT, is now the most sensitive tool available for detecting glaucoma early. It measures optic nerve fibre layer thickness with precision and can identify structural damage before any field defect appears. This means signs of glaucoma early can be found on OCT before the patient loses any measurable vision. This window of structural damage without functional loss is the ideal time to start treatment.

In Gurgaon and across India, access to OCT and Visual Fields is available at well-equipped glaucoma clinics. There is no reason to present with advanced disease when early detection is possible.

Known for her structured approach to glaucoma risk assessment and progression analysis, Dr Shibal Bhartiya provides trusted second opinions for patients seeking clarity before major treatment decisions. Both, in person, and online.

What Early Detection Looks Like (Before Symptoms Appear)

The goal is prevention, not reaction
Care is designed to preserve vision before symptoms ever occur.

Screening is not symptom-driven
Evaluation is based on risk — age, family history, optic nerve appearance — not complaints.

Peripheral vision testing is essential
Visual field tests detect changes patients cannot perceive themselves.

Optic nerve evaluation is central
Structural damage often precedes functional loss.

Baseline + progression tracking matters more than single visits
Glaucoma is diagnosed and managed over time, not in one consultation.

Subtle risk signals are taken seriously
Borderline findings are monitored, not dismissed.

Glaucoma Risk Factors: Who Should Be Tested and When

If you have one or more of the following glaucoma risk factors, you should have a comprehensive glaucoma evaluation now, regardless of whether you have any symptoms.

Age over 40 with no prior glaucoma screening, a first-degree relative with glaucoma, Indian ethnicity with narrow angles or high eye pressure, high myopia of minus 6 dioptres or more, diabetes with a history of eye complications, prolonged use of steroid eye drops or tablets, a previous eye injury, and thin corneas identified on any prior eye examination.

If none of these apply to you, a baseline glaucoma check at 40 is still strongly recommended. Early glaucoma symptoms will not tell you when to come. Your risk profile must guide you instead.

Signs of Glaucoma Early: What the Doctor Looks For

Signs of glaucoma early are visible to a trained examiner long before they are visible to the patient. A large or asymmetric optic cup, thinning of the neuroretinal rim, optic disc haemorrhages, and nerve fibre layer defects on OCT are all signs of glaucoma early that prompt further investigation and monitoring.

Visual field testing maps the area of vision in each eye. Characteristic glaucomatous field defects follow predictable patterns. A glaucoma specialist can identify these patterns at an early stage and begin treatment before the patient has noticed any functional change.

Detecting glaucoma early through regular specialist review is the most effective intervention available. There is no cure for glaucoma. There is no way to restore vision that has been lost. But there is an effective way to stop the damage progressing. That way is early diagnosis and consistent treatment.

What Happens If Glaucoma Goes Undetected

Glaucoma no symptoms early is a feature that works against patients who rely on symptoms to motivate healthcare visits. Without detection, the disease progresses. Peripheral vision narrows. Then central vision begins to fail. End stage glaucoma causes blindness that cannot be reversed. This trajectory takes years, sometimes decades. But it is one-directional. Vision once lost to glaucoma does not return.

The tragedy in most cases of advanced glaucoma is not that the disease was undetectable. It is that it went undetected. Symptoms of glaucoma in adults at a late stage are unmistakable. But by that point, the opportunity to preserve vision has passed.

You Cannot Feel Glaucoma Until It Is Too Late

Early glaucoma symptoms will not protect you. Your risk factors, your family history, and your age are the signals that matter. A comprehensive glaucoma evaluation by a fellowship-trained specialist is the only reliable way to know whether you have glaucoma before it has already taken something from you.

Do not wait for a warning that may never come.

SituationWhat Patients Often AssumeClinical Reality What Good Care Looks Like
No symptoms“My eyes feel normal”Most glaucoma is silent in early and moderate stagesScreening based on risk, not symptoms
Good central vision“I can read clearly, so vision is fine”Peripheral vision loss occurs firstVisual field testing to detect early loss
Daily activities normal“I can drive and work normally”Brain compensates for missing visual areasRegular monitoring despite normal function
Expecting pain/redness“Eye problems should cause discomfort”Common glaucoma types are painlessAwareness that absence of pain ≠ absence of disease
Sudden symptoms“I’ll know if something is wrong”Symptoms appear late, often after irreversible damageEarly detection before symptoms develop
One eye compensates“Vision seems fine overall”One eye can mask loss in the otherSeparate testing of each eye
Normal eye check-up“Doctor said everything is okay”Routine checks may miss glaucoma without specific testsComprehensive glaucoma evaluation (OCT + fields)
Single test normal“My report was normal”Disease is detected through change over timeBaseline + serial comparison
Understanding symptoms“Blurred vision means glaucoma”Blur is not a typical early signEducation about silent progression
Goal of care“Treat when symptoms start”Waiting for symptoms means late diseasePreventive, long-term monitoring approach

Frequently Asked Questions

What are the early symptoms of glaucoma?

In most cases, early glaucoma symptoms do not exist. Open angle glaucoma, the most common type, is entirely silent in its early and middle stages. There is no pain, no blurring, and no visual disturbance until significant optic nerve damage has already occurred. The only exception is acute angle closure glaucoma, which causes sudden pain, redness, and visual disturbance and requires emergency care.

Why glaucoma symptoms are often missed until it’s too late

Glaucoma is frequently missed because it develops silently, with no pain or early warning signs, while damage begins in the peripheral vision—which the brain can compensate for.
By the time noticeable symptoms like tunnel vision appear, irreversible optic nerve damage has often already occurred, making early, risk-based screening essential.

Can you have glaucoma with normal vision?

Yes. Many patients have 6/6 vision and still have optic nerve damage because central vision is affected late.

Does glaucoma always cause pain or redness?

No. The most common types of glaucoma are painless and silent. Pain occurs only in specific acute conditions.

How does glaucoma affect vision over time?

It causes gradual loss of peripheral vision, leading to tunnel vision in advanced stages if untreated.

Why don’t patients notice glaucoma early?

The brain compensates for missing visual areas, and daily activities remain normal, so damage goes unnoticed.

Can one eye compensate for glaucoma in the other?

Yes. One eye can mask vision loss in the other, which is why each eye must be tested separately.

Is blurred vision an early sign of glaucoma?

No. Blurred vision is not a typical early symptom. Glaucoma usually progresses without noticeable visual changes initially.

If my eye pressure is normal, can I still have glaucoma?

Yes. Normal-tension glaucoma is common, especially in India, and can progress despite normal pressure readings.

When do symptoms of glaucoma usually appear?

Symptoms typically appear late, when significant and irreversible vision loss has already occurred.

Can I check for signs of glaucoma early at home?

There is no reliable way to check signs of glaucoma early at home. You cannot measure intraocular pressure or examine your optic nerve without clinical equipment. What you can do is notice changes in peripheral vision, difficulty in dim light, or increased uncertainty when driving, and use these observations as prompts to see a glaucoma specialist. Symptoms of glaucoma at home are not a substitute for clinical testing.

Who is most at risk of glaucoma?

The main glaucoma risk factors are age over 40, a family history of glaucoma, Indian ethnicity, high myopia, diabetes, prolonged steroid use, previous eye injury, and thin corneas. People with any of these risk factors should have a comprehensive glaucoma evaluation regardless of symptoms. Glaucoma risk factors are the trigger for testing, not symptoms.

How is glaucoma detected before symptoms appear?

Detecting glaucoma early requires a full clinical examination including intraocular pressure measurement, optic nerve assessment, OCT imaging of the nerve fibre layer, and a visual field test. OCT can identify structural damage before any loss of vision occurs. This is the most valuable window for treatment. A routine vision test does not detect glaucoma.

What are the symptoms of glaucoma in adults at a late stage?

Late stage symptoms of glaucoma in adults include tunnel vision, difficulty navigating in low light, frequent collisions with objects in peripheral view, and eventually loss of central vision. These are signs that substantial and irreversible damage has already occurred. Detecting glaucoma early, before any of these symptoms appear, is the goal of regular specialist screening.

How often should I get checked for glaucoma if I have no symptoms?

Adults above 40 or those with risk factors should have regular eye exams every 1–2 years, even without symptoms.

What is the biggest mistake patients make about glaucoma symptoms?

Waiting for symptoms. By the time symptoms appear, damage is often permanent and advanced.


Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 94 PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Available on Pubmed and Google Scholar

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

Google Business Profile

Upload your reports for a structured review.

For people unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Family History & Glaucoma Screening

Family History & Glaucoma Screening– My Parent or Sibling Has Glaucoma. Do I Need to Get Tested Too? Short answer, YES. Having a first degree relative with glaucoma: a parent, sibling, or child, raises your lifetime risk of developing the disease by four to nine times compared to someone with no family history, says Dr Shibal Bhartiya.

Your parent or sibling has just been diagnosed with glaucoma. Or perhaps they have had it for years and you are only now realising what that means for you.

You are asking the right question. Most people do not ask it until it is too late. Dr Shibal Bhartiya explains more.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Why Family History Changes Everything in Glaucoma

Glaucoma is not random. It runs in families. Having a first degree relative with glaucoma: a parent, sibling, or child, raises your lifetime risk of developing the disease by four to nine times compared to someone with no family history.

That is not a small increase. That is a fundamental shift in your risk category.

And yet most first degree relatives of glaucoma patients never get tested. They wait for symptoms. Glaucoma does not produce symptoms until significant, often irreversible damage has already occurred. By the time your vision changes, the window for early intervention has often narrowed considerably.

This is why family history glaucoma screening exists: not to frighten you, but to find the disease before it finds you.


What Is the First Degree Relative Glaucoma Risk?

A first degree relative is a parent, sibling, or child: someone who shares approximately 50 percent of your genetic material.

The first degree relative glaucoma risk is well established in research. Studies consistently show that having one affected first degree relative raises your risk of developing primary open angle glaucoma to approximately 1 in 5. Having two affected first degree relatives raises it further.

The risk is highest when the affected relative developed glaucoma before the age of 60, when the disease was severe at diagnosis, or when the relative required surgery rather than drops alone.

First degree relative glaucoma risk is also higher in specific ethnic groups. People of African descent carry a higher baseline risk. In India, primary angle closure glaucoma has a higher prevalence than in Western populations, and this pattern also clusters in families.

Knowing your family history is not just useful. In glaucoma, it is clinically essential.


Does Having a Family History Mean You Will Definitely Get Glaucoma?

No. A family history raises your risk. It does not guarantee disease.

Many people with a strong family history never develop glaucoma. Many develop it only in their seventies or eighties, when treatment is straightforward and vision loss is entirely preventable with monitoring.

What family history means clinically is this: you belong in a higher-risk group that benefits from earlier, more frequent screening for glaucoma. That is all. It is not a sentence. It is a schedule.


Glaucoma Risk Factors Beyond Family History

Family history is the single strongest glaucoma risk factor after age. But it does not act alone. Several other glaucoma risk factors combine with family history to raise your personal risk further.

Age is the most consistent glaucoma risk factor across all populations. Risk rises steeply after 40 and continues to increase with each decade.

Raised eye pressure, also called ocular hypertension, is a major modifiable glaucoma risk factor. Not everyone with high eye pressure develops glaucoma, but the risk is substantially elevated, particularly when combined with family history.

Myopia (near-sightedness) increases glaucoma risk, particularly for primary open angle glaucoma. Moderate to high myopia is an independent glaucoma risk factor.

Thin corneas reduce the accuracy of eye pressure measurements and are independently associated with glaucoma progression risk.

Systemic conditions including diabetes, hypertension, and migraine are associated with higher glaucoma risk in some studies, particularly for normal tension glaucoma.

Previous eye injury or steroid use — whether eye drops, inhalers, skin creams, or oral steroids — can raise eye pressure and trigger steroid-induced glaucoma, particularly in genetically susceptible individuals.

When you combine a family history of glaucoma with one or more of these additional glaucoma risk factors, the case for early screening becomes compelling.


What Does Screening for Glaucoma in Adults Actually Involve?

Screening for glaucoma in adults is not a single test. It is a short, structured examination that covers the four main parameters of glaucoma assessment.

Eye pressure measurement — intraocular pressure is measured using a non-contact tonometer or applanation tonometry. This takes less than a minute. It is painless.

Optic nerve assessment — the ophthalmologist examines the optic disc through a dilated pupil or with specialist lenses. The size, shape, and symmetry of the optic nerve head are evaluated. This is the most important part of any glaucoma screening examination.

Corneal thickness measurement — pachymetry measures corneal thickness, which affects the interpretation of eye pressure readings.

OCT imaging — optical coherence tomography of the RNFL and optic nerve head provides structural data that can detect early glaucoma damage before any symptoms or visual field changes occur. You can read more about what an OCT scan shows and how to interpret your report.

Visual field testing — in higher-risk individuals, a visual field test maps peripheral and central vision to detect any functional loss.

Gonioscopy — in patients where angle closure is suspected, gonioscopy examines the drainage angle of the eye. This is particularly relevant in Indians, where angle closure glaucoma is more prevalent.

A complete screening for glaucoma in adults takes approximately 45 to 60 minutes at a specialist glaucoma clinic, including dilation time.


When Should Screening for Glaucoma Early Begin?

The timing of screening for glaucoma early depends on your personal risk profile.

For most adults with a first degree relative with glaucoma and no other risk factors, screening should begin at 40. Some guidelines recommend starting at 35 in high-risk ethnic groups or when the affected relative had early-onset disease.

For adults with a family history plus additional glaucoma risk factors: high myopia, raised eye pressure found incidentally, or very thin corneas, earlier screening is warranted. In these cases, a baseline examination in the mid-thirties is reasonable.

For adults with no family history and no other risk factors, screening for glaucoma in adults is generally recommended from the age of 40 as part of a routine comprehensive eye examination.

The question is not whether to screen. The question is when to start and how often to repeat.


How Often Should You Be Screened?

Frequency depends on what the first examination shows.

If the first screening is entirely normal: normal eye pressure, healthy optic nerve, normal OCT, annual or biennial review is appropriate for most people in the family history risk group.

If the first screening shows borderline findings: slightly elevated pressure, a suspicious optic disc, or mildly thin RNFL on OCT, more frequent monitoring is needed. Your glaucoma specialist will advise a specific schedule based on your individual findings.

If the first screening confirms early glaucoma, you move from a screening pathway to a treatment and monitoring pathway. Early glaucoma detected through family history glaucoma screening is almost always manageable, and vision loss is highly preventable with timely intervention.


Detecting Glaucoma Early: Why It Matters So Much

Glaucoma destroys retinal nerve fibres. Once those fibres are gone, they do not regenerate. The vision lost to glaucoma does not return.

Detecting glaucoma early changes the entire trajectory of the disease. A patient diagnosed at the very beginning of structural damage, before any visual field loss, has an excellent long-term prognosis with appropriate treatment. A patient diagnosed after significant optic nerve damage faces a harder, narrower path.

The difference between these two patients is often not biology. It is timing. It is whether someone in the family said: you should get checked, and whether the person listened.

Detecting glaucoma early through structured family history screening is one of the highest-value interventions in all of preventive ophthalmology. It costs very little. It changes lives.


What Happens If Glaucoma Is Found?

Finding glaucoma early through family history glaucoma screening is not bad news. It is good news delivered at the right time.

Early glaucoma in a screened patient is almost always managed with eye drops alone. Treatment is started, eye pressure is brought to a safe target, and the optic nerve is monitored regularly. Most patients with early glaucoma, managed well and consistently, never develop significant visual impairment.

The goal of glaucoma treatment is not to cure the disease. It is to slow it so completely that it never affects your quality of life. That goal is realistic. It is achieved every day for patients who are found early.

What changes if glaucoma is found is not your life. It is your schedule, a few extra clinic visits and a bottle of eye drops. That is the trade. For preserved vision over decades, it is a very good trade.


What If the Screening Is Normal?

A normal screening result is genuinely reassuring, but it is not a permanent all-clear.

Glaucoma can develop or progress at any age. A normal result at 40 means you do not have glaucoma now. It does not mean you will never develop it. This is why regular, repeated family history glaucoma screening matters more than a single normal result.

Think of it the way you think of blood pressure checks or dental appointments. A normal result today schedules your next check. It does not cancel all future checks.


Where to Get Screened in Gurgaon

If you have a family history of glaucoma and have not yet been assessed, a structured glaucoma risk evaluation with a glaucoma specialist in Gurgaon is the right next step.

A specialist assessment goes beyond a basic eye pressure check. It includes optic nerve imaging, corneal thickness measurement, OCT analysis, and visual field testing, and if indicated, gonioscopy. This gives you a complete, documented baseline against which future examinations can be compared.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram. She offers structured glaucoma risk assessments for patients with a family history of glaucoma, including those seeking a second opinion on existing results or diagnoses.

Appointments: +91 88826 38735

Upload your reports for a structured review.


Gentle Takeaway

Your parent’s diagnosis is information. It is not fate.

The single most useful thing you can do with that information is act on it earlybefore symptoms, before damage, before the window narrows.

Glaucoma caught early is a very manageable disease. Glaucoma caught late is a much harder conversation. The difference is often a single timely appointment.

Book one.

Family History as a Glaucoma Risk Trigger, Not a Footnote

A positive family history remains one of the most clinically actionable risk signals in glaucoma, yet also one of the most under-leveraged.

First-degree relatives of patients with glaucoma have a substantially higher lifetime risk (often 3–4× or more), and importantly, may develop disease earlier and with more aggressive trajectories.

Dr Bhartiya’s editorial along with geneticists from AIIMS, New Delhi and Marengo Asia, emphasises on integrating genomics into practice (PMID: 41523176), reinforcing that family history is not merely a background detail but a proxy for inherited susceptibility that should actively trigger structured screening pathways.

In practical terms, this shifts glaucoma care from opportunistic detection to targeted risk-based screening, where identifying and counselling family members becomes a core extension of clinical responsibility, not an optional add-on.

Clinical Reality (Family History & Glaucoma Screening in India)

  • Family history is one of the strongest risk factors — but often ignored
    Many patients only realise its importance after damage has already occurred.
  • Screening is not routine for relatives
    Unlike diabetes or hypertension, glaucoma screening is rarely proactively advised to family members.
  • “No symptoms” delays first check
    High-risk individuals often wait for visual complaints, by which time disease may already be advanced.
  • Normal eye check-ups may miss early glaucoma
    Routine vision tests without optic nerve evaluation or fields can miss disease.
  • Younger family members are often overlooked
    Screening is delayed until later decades, despite risk beginning earlier.
  • One normal test gives false reassurance
    A single normal OCT or pressure reading does not rule out future risk.

What Good Screening Looks Like (If You Have a Family History of Glaucoma)

  • Early baseline screening — before symptoms
    Ideally by age 30–40, or earlier if multiple affected relatives.
  • Comprehensive evaluation, not just vision or pressure
    Includes optic nerve assessment, OCT, visual fields, corneal thickness.
  • Risk-stratified follow-up
    Frequency depends on baseline findings — not “come if needed.”
  • Family-based screening approach
    First-degree relatives (parents, siblings, children) are actively advised evaluation.
  • Longitudinal monitoring
    Tracking change over time is key — not single reports.
  • Clear patient education
    Understanding risk improves adherence to follow-up and screening.

Family History & Glaucoma Screening: What’s Missed vs What Matters

SituationWhat Patients Often AssumeClinical Reality (India Context)What Good Care Looks Like
Family history present“It’s not affecting me yet”Risk is significantly higher even without symptomsEarly baseline screening for all first-degree relatives
No symptoms“I’ll get checked if I notice a problem”Glaucoma remains silent until irreversible damageScreening before symptoms begin
Routine eye check-up“My eyes were checked, so I’m fine”Standard vision tests may miss early glaucomaComprehensive glaucoma evaluation (OCT + fields + nerve exam)
Age factor“I’m too young to worry”Risk can begin earlier in those with family historyScreening from 30–40 years or earlier if high risk
Single normal report“Everything was normal last time”One test cannot rule out future progressionPeriodic follow-up based on risk profile
Family awareness“No one told my family to get tested”Screening advice is often not extended to relativesProactive, family-based screening approach
Follow-up“I’ll come back if needed”Irregular follow-up delays detection of early changesStructured, risk-based follow-up intervals
Understanding risk“It’s just genetic, nothing to do now”Early detection can prevent vision lossEducation + long-term monitoring strategy
Disease perception“Glaucoma means high pressure only”Many patients develop glaucoma at normal pressuresBroader risk assessment beyond IOP
Goal of screening“Just to rule it out”Screening is about early detection and tracking changeLong-term risk management, not one-time clearance

Frequently Asked Questions: Family History and Glaucoma Screening

Does glaucoma run in families?

Yes. Having a first degree relative: a parent, sibling, or child with glaucoma raises your lifetime risk of developing the disease by four to nine times. Family history is the single strongest glaucoma risk factor after age. Structured family history glaucoma screening is recommended for all first degree relatives of glaucoma patients.

What is the risk of glaucoma if a parent has it?

The first degree relative glaucoma risk is approximately 1 in 5 for primary open angle glaucoma, significantly higher than the general population risk of around 1 in 50. The risk is higher when the affected parent developed glaucoma early, had severe disease, or required surgery.

At what age should I get screened for glaucoma if a parent has it?

Screening for glaucoma early should begin at 40 for most adults with a first degree relative with glaucoma. Those with additional glaucoma risk factors, high myopia, raised eye pressure, or thin corneas, should consider a baseline examination from the mid-thirties.

What does glaucoma screening involve?

Screening for glaucoma in adults includes eye pressure measurement, optic nerve assessment through a dilated pupil, corneal thickness measurement, OCT imaging of the nerve fibre layer, and visual field testing in higher-risk individuals. A complete specialist assessment takes approximately 45 to 60 minutes.

Can glaucoma skip a generation?

Yes. The genetic inheritance pattern of glaucoma is complex and not fully understood. Glaucoma can skip generations or manifest differently across family members. A negative family history in your parents does not fully exclude risk if grandparents or siblings are affected.

What glaucoma risk factors increase my risk beyond family history?

Key glaucoma risk factors that combine with family history include age over 40, raised eye pressure, moderate to high myopia, thin corneas, diabetes, and previous steroid use. The more risk factors present alongside family history, the stronger the case for early and frequent screening.

If my glaucoma screening is normal, do I still need follow-up?

Yes. A normal result at first screening does not mean permanent all-clear. Glaucoma can develop at any point. Annual or biennial review is recommended for adults with a family history of glaucoma, even when the initial assessment is entirely normal.

Book a consultation with Dr Shibal Bhartiya:

Marengo Asia Hospitals, Gurugram

Phone: +91 88826 38735

Website: drshibalbhartiya.com

Google Business Profile: maps.app.goo.gl/mcfegmHTuhqV5hSp6

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Glaucoma in India: Why the Risk Is Higher Than You Think

Glaucoma is the most common cause of irreversible blindness in India, and 90% of cases remain undiagnosed. That means nine out of every ten people with glaucoma in this country do not know they have it. An estimated 11.2 million Indians aged 40 and above have glaucoma. And angle closure glaucoma is more common in India, than in the West, says Dr Shibal Bhartiya. Glaucoma in India is often missed or undertreated because it progresses silently, even when vision and eye pressure appear normal. Good glaucoma care focuses on early detection, risk-based monitoring, and long-term protection of vision, not just adding more eye drops.

Glaucoma does not give you a warning. You lose peripheral vision first. By the time you notice something is wrong, damage is already done. The good news is that glaucoma detected early is highly manageable. Blindness from glaucoma is largely preventable with timely diagnosis and consistent treatment.

In India, this story plays out every day at a scale that is hard to comprehend. Dr Shibal Bhartiya, fellowship trained glaucoma specialist in Gurgaon, explains more about Glaucoma in India, and Indians.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


Why Indians Are at Higher Risk

Indians carry specific anatomical and genetic traits that raise their glaucoma risk. One of the most significant is a shallower anterior chamber angle. This makes angle-closure glaucoma far more common in Indian and South Asian eyes than in Western populations.

Primary angle-closure disease may affect as many as 27.6 million Indians. Patients with primary angle-closure glaucoma are twice as likely to go blind compared to those with open-angle glaucoma. Yet this form is frequently missed or misdiagnosed.

Indians also present with glaucoma at a younger age than patients in Western populations. Juvenile open-angle glaucoma, which begins between the ages of 16 and 40, is well documented in Indian tertiary centre data. A family history of glaucoma raises your personal risk significantly. If a parent or sibling has glaucoma, your chances of developing it are much higher.

Other risk factors specific to the Indian context include:

Steroid use without medical supervision, myopia (short-sightedness), diabetes, and a family history of glaucoma are all important risk factors to discuss with your doctor.


The Problem of Late Presentation

Most glaucoma in India is detected late. Very late.

In India, undetected and untreated glaucoma leads to faster progression, earlier visual impairment, and preventable blindness. The core reason is that glaucoma causes no pain and no blur in the early stages. People feel completely fine. They see no reason to visit an eye doctor.

By the time central vision is affected, up to 90% of peripheral nerve fibres may already be lost. That damage cannot be reversed. No surgery, no medication, and no intervention brings that vision back.

This is what makes early screening so critical. You cannot feel glaucoma coming. You can only catch it on examination.


The Scale of the Problem in India

Glaucoma prevalence among Indians aged 40 and above ranges between 2.7% and 4.3% across multiple population-based studies. In those over 70 years of age, the risk rises sharply. Studies show glaucoma affects over 8% of Indians in their seventies and over 14% of those above 80.

Glaucoma is a leading cause of irreversible blindness globally, and the burden in Asia and India is expected to grow substantially by 2040.

India does not have enough glaucoma specialists to manage this burden. Most patients are diagnosed and managed by general ophthalmologists. Structured, specialist-led care makes a real difference to outcomes.


What Makes Glaucoma in Indians Different to Manage

Treating glaucoma in an Indian patient requires a different approach than using a standard Western protocol.

Indian eyes tend to have thinner corneas. Corneal thickness affects how accurately we measure intraocular pressure (IOP). A thin cornea can make the pressure appear lower than it actually is. This leads to underdiagnosis and undertreatment. Also, thinner corneas are an independent risk factor for glaucoma progression.

Angle-closure disease needs gonioscopy, a specialised examination to assess the drainage angle of the eye. Studies have found that a significant proportion of patients in India are incorrectly treated for open-angle glaucoma when they actually have angle-closure disease.The treatment for these two types is fundamentally different.

Normal tension glaucoma (NTG), where optic nerve damage occurs despite normal eye pressure, is also seen in Indian patients. This form requires looking beyond IOP and addressing other risk factors including blood pressuresleep patterns, and vascular health.


How I Approach Glaucoma in Indian Patients

I have spent 25+ years specialising in glaucoma. I see this disease in its full Indian context, not through a textbook written for another population.

My clinical approach includes a full angle assessment with gonioscopy for every new patient, corneal thickness measurement to ensure accurate pressure readings, structural imaging with OCT to detect early nerve fibre loss, visual field analysis (with special emphasis on reliability criteria) and a detailed risk factor review including family history, steroid use, and systemic health.

Correct classification, open-angle versus angle-closure, changes treatment completely. Getting this right at the first visit prevents years of inadequate care.

I also believe in clear communication. Glaucoma is a lifelong condition. You need to understand what you have, why treatment matters, and what to monitor. I take the time to explain this at every visit.

If you have a family history of glaucoma, are over 40, have diabetes, are short-sighted, or use steroid eye drops, you need a glaucoma screening now.


Clinical Reality (What’s Not Always Obvious in Glaucoma Care in India)

  • Normal vision does not mean no glaucoma
    Many patients read 6/6 and still have significant optic nerve damage.
  • Symptoms are often absent until late
    Glaucoma is typically silent — by the time patients notice vision loss, it is often irreversible.
  • Eye pressure (IOP) alone is not enough
    Patients can progress despite “normal” pressures — especially in normal-tension glaucoma, which is common in India.
  • Tests in isolation can mislead
    A single OCT or visual field report cannot define disease. Progression over time is what matters.
  • Cataract and glaucoma often coexist — but are not interchangeable explanations
    Improving vision after cataract surgery does not mean glaucoma risk is gone.
  • More medications ≠ better control
    Multiple drops without a clear long-term plan often reflect escalation without strategy.
  • Follow-up gaps are a major cause of vision loss
    Irregular monitoring is one of the biggest real-world failures in glaucoma care.
  • Family history is under-recognised and under-screened
    Many high-risk individuals in India are never examined until damage has already occurred.

What Good Glaucoma Care Looks Like (Indian Context)

  • Early risk identification — even before symptoms
    Screening is guided by age, family history, corneal thickness, optic nerve appearance — not just complaints.
  • Baseline documentation and longitudinal tracking
    OCT and visual fields are used to establish a baseline and detect change, not just diagnose once.
  • Target pressure is individualised
    Treatment is tailored based on stage of disease, risk profile, and rate of progression — not a fixed number.
  • Medication strategy is structured, not reactive
    Each drop has a purpose. Escalation is thoughtful, not additive.
  • Patient understanding is prioritised
    Patients are told what to watch for: subtle visual changes, adherence issues, side effects.
  • Consistency over intensity
    Regular follow-up (every 3–6 months depending on risk) matters more than aggressive but irregular care.
  • Second opinions are used appropriately
    Especially when:
    • Disease is progressing despite treatment
    • Multiple medications are being used
    • Surgery is being considered
  • The goal is not just seeing clearly — but seeing safely for life
    Glaucoma care is long-term risk management, not short-term vision correction.

Remember

SituationWhat Patients Often AssumeClinical Reality (India Context)What Good Care Looks Like
Vision is normal“I can see clearly, so everything is fine”Glaucoma can cause optic nerve damage even with 6/6 visionRisk-based screening and optic nerve evaluation, even without symptoms
No symptoms“No discomfort means no disease”Glaucoma is silent until late stagesEarly detection through structured exams, not symptom-driven visits
Eye pressure (IOP)“My pressure is normal, so I’m safe”Progression can occur even at normal IOP (common in India)Individualised target IOP based on risk and progression
Single test reports“My OCT/field test is normal”One report is not enough — change over time mattersBaseline + serial comparison to detect progression
Cataract vs glaucoma“Cataract surgery fixed my vision, so I’m okay”Cataract improvement can mask underlying glaucomaParallel evaluation of optic nerve even in cataract patients
Multiple eye drops“More drops means stronger treatment”Overmedication may reflect lack of strategyStructured medication plan with defined goals
Follow-up gaps“I’ll come back if I feel a problem”Irregular follow-up is a major cause of preventable vision lossScheduled monitoring every 3–6 months based on risk
Family history“No one told me to get checked”High-risk individuals often remain unscreened in IndiaProactive screening for family members
Treatment approach“Doctor will adjust if needed”Reactive care often misses slow progressionLong-term planning with defined targets and timelines
Understanding disease“Drops are enough”Poor understanding leads to poor adherenceClear patient education on disease, risks, and expectations
Escalation decisions“Add another drop if pressure rises”Escalation without strategy leads to confusion and side effectsStepwise, purpose-driven escalation or de-escalation
Goal of care“I just need to see clearly”Vision clarity ≠ visual safetyFocus on lifelong preservation of functional vision

FAQs: Glaucoma in Indians

Is glaucoma more common in Indians?

Yes. Indians face a higher risk than many Western populations for two main reasons. First, Indian eyes tend to have a shallower drainage angle, which makes angle-closure glaucoma significantly more common. Second, glaucoma in Indians often develops at a younger age and is detected later, by which time substantial nerve damage has already occurred.


Can Indians get glaucoma even with normal eye pressure?

Yes. Normal tension glaucoma (NTG) occurs when the optic nerve is damaged despite intraocular pressure readings within the normal range. This form is well documented in Indian patients. It is one reason why pressure measurement alone is not enough. A full glaucoma evaluation includes optic nerve imaging and visual field testing.


What are the early signs of glaucoma in Indians?

In most cases, there are no early signs. Glaucoma is called the silent thief of sight because it causes no pain and no blurred vision until the disease is advanced. Peripheral vision goes first, and most people do not notice this until significant damage has occurred. The only reliable way to detect early glaucoma is a comprehensive eye examination.


Who should get screened for glaucoma in India?

Anyone over 40 should have a baseline glaucoma check. Screening is especially important if you have a family history of glaucoma, are short-sighted, have diabetes, use steroid eye drops, or have previously been told your eye pressure is elevated. Earlier screening is recommended if more than one risk factor applies.


How is glaucoma treated in Indian patients?

Treatment depends on the type of glaucoma. Angle-closure glaucoma, which is more common in Indians, often requires laser treatment (laser peripheral iridotomy) in addition to or instead of eye drops. Open-angle glaucoma is typically managed with pressure-lowering drops, laser, or surgery. The right treatment must be matched to the specific type of glaucoma you have, which is why correct diagnosis through gonioscopy and full assessment is essential.

If you have been told you have glaucoma but have not had gonioscopy or a visual field or OCT imaging, a structured second opinion can clarify your diagnosis and treatment plan.

Book a consultation with Dr Shibal Bhartiya:

Marengo Asia Hospitals, Gurugram

Phone: +91 88826 38735

Website: drshibalbhartiya.com

Google Business Profile: maps.app.goo.gl/mcfegmHTuhqV5hSp6

Read the research articles

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was updated in May 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks, span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Available on Pubmed and Google Scholar

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

Patient reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Steroid Induced Glaucoma

Steroids carry a risk that many patients, and even some prescribing doctors, overlook. They can silently raise the pressure inside your eye. And raised eye pressure, left unchecked, damages the optic nerve and causes glaucoma, says Dr Shibal Bhartiya. Timely monitoring, not waiting for symptoms, is what prevents irreversible optic nerve damage.

Steroids are powerful medicines. Doctors use them to treat inflammation, autoimmune disease, allergies, and dozens of other conditions. But they can trigger a silent rise in eye pressure, often without early symptoms.

This condition is called steroid-induced glaucoma. It is one of the most preventable causes of serious vision loss in India.


Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.


What Are Steroids and Why Do Doctors Use Them?

Steroids, specifically corticosteroids, reduce inflammation in the body. Doctors prescribe them in many forms: eye drops, oral tablets, inhalers, nasal sprays, skin creams, and injections directly into or around the eye.

Common brand names include prednisolone, dexamethasone, betamethasone, triamcinolone, and budesonide. Many are available over the counter in India without a prescription. This is a serious problem.

People often self-medicate with steroid eye drops for redness or allergy, sometimes for months, without any eye pressure monitoring.


How Do Steroids Raise Eye Pressure?

Your eye constantly produces a fluid called aqueous humour. This fluid drains out through a mesh-like structure called the trabecular meshwork. Steroids interfere with this drainage. The fluid builds up. Pressure inside the eye rises.

This process is called a steroid response. It does not happen to everyone. But certain people are far more susceptible. Glaucoma patients, first-degree relatives of glaucoma patients, people with high myopia, and diabetics have a higher risk of becoming steroid responders.

In a steroid responder, eye pressure can rise significantly, sometimes within days of starting treatment. More often, the rise is gradual and goes unnoticed for weeks or months.

The danger is that raised eye pressure causes no pain. No redness. No blurring. You feel nothing until the optic nerve is already damaged.


Which Steroids Carry the Highest Risk?

Eye drops carry the greatest risk. They deliver steroids directly into the eye in concentrated form. Potent drops like prednisolone and dexamethasone raise eye pressure more than weaker formulations like fluorometholone or loteprednol. Duration matters too: the longer the use, the greater the risk.

Periocular injections, injections around the eye used in uveitis and retinal disease, release steroids slowly over weeks to months. Triamcinolone acetonide injections are a particularly common cause of prolonged eye pressure elevation. Once the depot is in place, it cannot be removed easily.

Oral steroids carry a lower but real risk, especially with prolonged use at high doses.

Inhaled steroids for asthma and COPD, and nasal sprays for allergic rhinitis, carry a small but measurable risk, particularly with long-term use.

Skin creams applied around the eyes can absorb through the eyelid skin and raise eye pressure. This is underappreciated and often missed.


Symptoms of Steroid-Induced Glaucoma

In most cases, there are no symptoms. This is what makes steroid-induced glaucoma dangerous.

By the time vision changes become noticeable, significant optic nerve damage has often already occurred. Peripheral vision goes first — and most people do not notice peripheral vision loss until it is severe.

In rare cases, when eye pressure rises very rapidly, patients may experience headache, eye ache, blurring, or haloes around lights. But this is the exception, not the rule.

The only way to detect steroid-induced glaucoma early is to check eye pressure regularly while on any steroid therapy, especially eye drops.


How Is Steroid-Induced Glaucoma Diagnosed?

Diagnosis requires a full glaucoma evaluation. This includes:

Tonometry measures eye pressure. Normal pressure is usually between 10 and 21 mmHg. Steroid responders may reach 30, 40, or even higher.

Gonioscopy examines the drainage angle to confirm the trabecular meshwork is open, as it is in steroid glaucoma, distinguishing it from angle-closure glaucoma.

OCT (Optical Coherence Tomography) scans the optic nerve and the nerve fibre layer to detect structural damage before vision loss is symptomatic.

Visual field testing maps the field of vision to detect functional loss.

Optic disc examination allows direct visualisation of the nerve head for signs of damage and cupping.

Steroid-induced glaucoma looks identical to primary open-angle glaucoma on examination. The distinguishing clue is the history: elevated pressure that developed after starting a steroid, and that improves when the steroid is stopped or changed.


Is Steroid-Induced Glaucoma Reversible?

The short answer: sometimes, if caught early enough.

In many patients, stopping or switching the steroid allows eye pressure to normalise within weeks. If the optic nerve has not been damaged, the condition is fully reversible.

But optic nerve damage is permanent. Glaucoma does not recover. If pressure has been high long enough to injure the nerve, even partially, that damage remains even after the steroid is stopped.

This is why early detection is critical. A short course of steroid eye drops that goes unmonitored can cause permanent vision loss that no treatment can reverse.

Caught early, steroid glaucoma is one of the most manageable forms of glaucoma. That is why monitoring matters.


Treatment Options

Step one is always to reconsider the steroid.

Can the dose be reduced? Can the steroid be stopped? Is there a possibility of using a less potent formulation? For eye drops, switching from prednisolone to fluorometholone or loteprednol often reduces the pressure response significantly.

Sometimes the underlying condition, uveitis, for example, requires continued steroid treatment. In these cases, eye pressure must be managed medically.

Pressure-lowering eye drops are the first line of treatment. The same drops used in primary glaucoma: prostaglandin analogues, beta-blockers, carbonic anhydrase inhibitors, and alpha agonists, are effective in steroid glaucoma.

Laser treatment (SLT) can improve drainage through the trabecular meshwork and reduce dependence on drops.

Surgery: trabeculectomy or a glaucoma drainage device , is reserved for cases where drops and laser do not control pressure adequately. Surgery in steroid glaucoma is generally highly effective.

For patients who have received a periocular steroid injection and cannot have it removed, sustained medical treatment is the mainstay until the depot is absorbed.


The Indian Context: A Hidden Epidemic

India has a particular problem with steroid-induced glaucoma. Steroid eye drops are widely available without prescription. Patients self-treat for red eyes, allergy, and post-operative care, often on the advice of pharmacists or non-specialist practitioners.

Many patients arrive in my clinic having used potent steroid drops every day for six, twelve, or even twenty-four months. Their pressure is grossly elevated. The optic nerves are damaged. Their peripheral vision is affected and will not return.

This is preventable. Every patient using steroid eye drops needs their eye pressure monitored. Every patient on long-term systemic steroids deserves at least an annual eye check. This is not optional.

As a fellowship-trained glaucoma specialist seeing patients from across India, Dr Bhartiya offers structured steroid glaucoma risk assessments for patients on long-term steroid therapy, including those referred by other treating doctors.


When Should You See a Glaucoma Specialist?

See a fellowship-trained glaucoma specialist if:

  • You are using steroid eye drops for more than two weeks
  • You have been prescribed a periocular steroid injection
  • You are on long-term oral steroids and have never had your eye pressure checked
  • You have a family history of glaucoma and are on any steroid therapy
  • You are a known glaucoma patient who requires steroids for any reason
  • Your eye pressure has been noted to be high on a routine eye check
  • If you have been told your eye pressure is high while on steroids, an independent glaucoma second opinion can clarify whether treatment or monitoring is needed.

Do not wait for symptoms. There are none, until it is too late. Bring your steroid prescription and any previous eye pressure readings to your appointment.


Clinical Reality (What’s not always obvious)

  • Steroid-induced glaucoma is often silent in the early stages
  • Vision may remain completely normal on routine testing
  • Pressure rise can happen within weeks in some patients, but months in others
  • Not all steroids are equal — eye drops, skin creams, inhalers, and even nasal sprays can contribute
  • The response is individual — some people are “steroid responders” without knowing it
  • Stopping the steroid does not always reverse the damage completely
  • Damage, once established, follows the same irreversible course as primary glaucoma

What Actually Helps (And What Doesn’t)

What helps:

  • Early identification of steroid use (even non-ocular forms)
  • Baseline and follow-up intraocular pressure monitoring
  • Switching to safer alternatives where possible
  • Timely initiation of anti-glaucoma therapy if needed
  • Long-term monitoring even after stopping steroids

What doesn’t help:

  • Assuming “short-term use is always safe”
  • Ignoring non-eye steroid sources (dermatology creams, inhalers)
  • Relying only on vision clarity as a marker of safety
  • Delaying evaluation because symptoms are absent
  • Repeated steroid prescriptions without pressure monitoring

Remember This

Situation / TriggerWhat Patients Often AssumeClinical RealityWhat Should Be Done
Using steroid eye drops“Doctor prescribed it, so it’s safe”Even prescribed steroids can raise eye pressureMonitor IOP within weeks of starting
Using skin creams near eyes“It’s just topical, not affecting eyes”Periocular absorption can increase eye pressureInform ophthalmologist and monitor
Using inhalers for asthma“It doesn’t reach the eye”Chronic use can contribute to pressure risePeriodic eye pressure checks
Short-term steroid use“Too brief to cause harm”Some individuals respond rapidlyEarly follow-up is essential
No symptoms“If I see well, everything is fine”Glaucoma damage is silent initiallyRegular screening, not symptom-based
Stopping steroids“Problem is solved now”Damage may persist or progressContinued monitoring required
Multiple steroid prescriptions“Different doctors, different issues”Cumulative exposure increases riskCentralised tracking of steroid use

Frequently Asked Questions

Can steroid eye drops cause glaucoma even when used for a short time?

A brief course, less than two weeks, rarely causes a clinically significant pressure rise. But risk increases with duration and potency. Any steroid eye drop use lasting more than two weeks warrants a pressure check.

How long does it take for steroids to raise eye pressure?

In highly susceptible individuals, pressure can rise within days. In most steroid responders, the rise occurs over two to six weeks of use. With depot injections, pressure may continue to rise for months.

Does stopping the steroid cure steroid glaucoma?

It normalises the pressure in most patients, yes. But if the optic nerve has already been damaged, that damage is permanent. Stopping the steroid does not restore lost vision.

Can inhaled steroids for asthma cause glaucoma?

Yes, though the risk is lower than with eye drops. Long-term use of high-dose inhaled corticosteroids has been associated with a modest increase in glaucoma risk, particularly in patients who already have elevated eye pressure.

Can steroid skin creams cause glaucoma?

Yes. Creams applied to the face and eyelid skin can absorb into the eye in meaningful amounts. This is an underrecognised cause of steroid-induced ocular hypertension.

What is a steroid responder?

A steroid responder is someone whose eye pressure rises significantly on steroid therapy. Roughly 5% of the general population are high responders. Glaucoma patients, first-degree relatives of glaucoma patients, high myopes, and diabetics have a much higher rate of response.

Is steroid glaucoma the same as regular glaucoma?

The optic nerve damage is identical. The mechanism of pressure elevation differs: steroids impair drainage through the trabecular meshwork. The treatment approach is similar, but the critical first step is always to reassess and if possible stop or reduce the causative steroid.

Can I still use steroids if I have glaucoma?

Yes, but only under close specialist supervision with frequent pressure monitoring. Never use steroid eye drops without the oversight of an ophthalmologist if you have a diagnosis of glaucoma or a family history of the condition.

I had a steroid injection around my eye six months ago and my pressure is still high. What should I do?

This is a recognised complication of periocular depot steroids. The injection releases slowly over months. Pressure management with drops or laser is usually required until the depot is absorbed. See a glaucoma specialist, this situation requires careful, ongoing monitoring.

What should I do if my pharmacist gives me steroid eye drops for a red eye?

Do not use steroid eye drops without a diagnosis from an ophthalmologist. Red eyes have many causes, viral conjunctivitis, allergic conjunctivitis, dry eye, most of which do not always require steroids and some of which can be worsened by them. Always get a proper diagnosis before using any steroid eye drop.


Book a consultation with Dr Shibal Bhartiya:

Marengo Asia Hospitals, Gurugram

Phone: +91 88826 38735

Website: drshibalbhartiya.com

Google Business Profile: maps.app.goo.gl/mcfegmHTuhqV5hSp6

Read the research articles

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. This article was edited in April 2026.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Available on Pubmed and Google Scholar

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

Patient reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic, you can opt for a teleconsult.

5 Mistakes Patients Make in Glaucoma Care

The five most common mistakes glaucoma patients make are: stopping eye drops when vision feels stable, missing follow-up appointments, ignoring family risk, self-managing side effects without telling their doctor, and assuming normal eye pressure means they are safe. Each mistake can silently accelerate nerve damage before any symptom appears, explains Dr Shibal Bhartiya.

Dr Shibal Bhartiya is a fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator with over 25 years of experience. Her approach focuses on identifying risk before damage is irreversible, simplifying treatment decisions, and protecting vision long-term. Emphasis on early detection, risk assessment, and continuity of care. She is rated 5 stars across 1,500+ patient reviews on Google.

Glaucoma is called the silent thief of sight for a reason. Most patients feel nothing until the damage is severe. That silence is exactly what makes certain habits so dangerous. These five mistakes are not careless choices. They are logical responses to a disease that gives no pain, no blur, and no warning. Understanding why each mistake happens is the first step to avoiding it.


5 Mistakes Glaucoma Patients Commonly Make

Mistake 1: Stopping Eye Drops When Vision Feels Fine

What patients do: They use drops for a few weeks, vision feels unchanged, and the drops get quietly abandoned. Life gets busy. The bottle runs out. It feels pointless to medicate something that causes no symptoms.

Why this is dangerous: Glaucoma drops do not improve vision. They protect the optic nerve from further damage. Stopping them does not feel like anything in the short term. But intraocular pressure rises within days of missing doses, and nerve damage accumulates silently over months.

What doctors often miss saying: Patients are rarely told that the goal of treatment is preservation, not improvement. When that is not explained clearly, stopping drops feels like a rational choice.

Real-world picture: Studies show that over 50% of glaucoma patients have poor drop adherence within one year of diagnosis. Many do not tell their doctor. Pressure readings at clinic visits look normal because patients resume drops a few days before their appointment.


Mistake 2: Skipping Follow-Up Appointments

What patients do: They feel well, work is busy, travel is expensive, and the appointment gets pushed by a month, then three months, then indefinitely.

Why this is dangerous: Glaucoma progression is invisible to the patient. Visual field loss in early and moderate glaucoma occurs in the peripheral vision first. Patients do not notice it in daily life. Only structured testing at follow-up reveals whether the nerve is stable or declining.

What doctors often miss saying: The frequency of follow-up is not arbitrary. It is calibrated to the rate of progression risk. Missing two visits in a year can mean missing a window to escalate treatment before irreversible loss occurs.

Real-world picture: A patient who feels fine and delays follow-up for six months may arrive to find their visual field has worsened by a measurable step. That step cannot be reversed.


Mistake 3: Ignoring Family History as a Personal Risk Signal

What patients do: A parent or sibling has glaucoma. The patient assumes they will know if they develop it too. They wait for symptoms before seeking screening.

Why this is dangerous: A first-degree family history of glaucoma increases personal risk by four to nine times. Glaucoma runs in families and often presents a decade earlier in the next generation. Waiting for symptoms means waiting until 30 to 40 percent of nerve fibres are already gone.

What doctors often miss saying: Screening is not just for people who already have symptoms. It is most valuable precisely when there are no symptoms yet.

Real-world picture: Many patients present to a glaucoma clinic only after a family member goes blind. By that point their own disease is already moderate or advanced.


Mistake 4: Managing Side Effects Silently Instead of Telling the Doctor

What patients do: Eye drops cause redness, stinging, darkened lashes, or a persistent dry eye feeling. Patients tolerate it quietly or stop the drops without informing anyone. They assume this is just how glaucoma treatment feels.

Why this is dangerous: Side effects are one of the most common reasons for treatment failure. Patients who stop drops due to side effects but do not report it appear adherent on their records. Pressure goes uncontrolled. The doctor has no reason to switch the formulation or try a preservative-free option.

What doctors often miss saying: There are multiple drop classes, combination formulations, and preservative-free alternatives. No patient needs to tolerate a drop that makes their eyes miserable. Laser treatment is also a first-line option that removes the drop burden entirely for many patients.

Real-world picture: A switch from a preserved to a preservative-free prostaglandin analogue resolves surface irritation in most patients within four to six weeks. Many patients never knew this option existed.


Mistake 5: Believing Normal Eye Pressure Means No Glaucoma Risk

What patients do: They have an eye check, are told pressure is normal, and conclude they do not have glaucoma and never will.

Why this is dangerous: Normal tension glaucoma is a well-documented condition in which nerve damage progresses despite intraocular pressure within the statistically normal range. In South Asian and East Asian populations this pattern is particularly common. Additionally, what is normal for the population may not be safe for a specific individual nerve.

What doctors often miss saying: Glaucoma diagnosis requires examination of the optic nerve, retinal nerve fibre layer imaging, and visual field testing. Pressure alone does not rule it out.

Real-world picture: Normal tension glaucoma accounts for a significant proportion of glaucoma in India. Patients with a normal pressure reading and a cupped nerve need full evaluation, not reassurance.


What This Table Shows You

MistakeWhat Patients BelieveThe Clinical Reality
Stopping dropsVision is stable so drops are not neededDrops preserve nerve, not vision
Missing follow-upNo symptoms means no progressionProgression is invisible without testing
Ignoring family historySymptoms will warn them in timeRisk is high and silent from the start
Tolerating side effectsThis is how treatment always feelsAlternatives exist; tell your doctor
Trusting normal pressureNormal IOP means no glaucomaNormal tension glaucoma is common in India

When to Worry

Seek an urgent glaucoma review if you notice any of the following. Sudden eye pain or headache with blurred vision and halos around lights. A family member has been recently diagnosed with glaucoma. Your vision seems to have narrowed or you are missing objects at the side. You have been using drops irregularly for more than one month. You have not had an optic nerve assessment in over a year.


What This Means for You

Glaucoma is manageable. Most patients who lose vision do so not because treatment failed but because the disease was caught late, treatment was abandoned, or follow-up was missed. None of these are irreversible situations if caught in time. The single most protective thing you can do is stay engaged with your care even when everything feels normal.


Frequently Asked Questions

Can glaucoma get worse even if I use my drops every day?

Yes. Drops reduce intraocular pressure but progression can continue in some patients despite good pressure control. This is why regular follow-up and nerve imaging remain essential even with perfect adherence.

How often should a glaucoma patient see their doctor?

Most stable patients need review every three to six months. Patients with active progression or recent treatment changes may need monthly visits. Your doctor will set the schedule based on your specific risk.

Is glaucoma hereditary and should my children be tested?

Yes, glaucoma has a strong hereditary component. First-degree relatives of a glaucoma patient should have a full eye examination including optic nerve assessment from the age of 35, or earlier if they have other risk factors.

What should I do if my eye drops are causing side effects?

Tell your doctor at the next visit and do not stop drops without guidance. There are multiple formulations, preservative-free options, and laser alternatives that may suit you better. Side effects are a solvable problem.

Does normal eye pressure rule out glaucoma?

No. Normal tension glaucoma is well recognised and common in Indian patients. A complete glaucoma evaluation includes optic nerve examination and imaging, not pressure measurement alone.


Speak to a Glaucoma Specialist

If you have been diagnosed with glaucoma and are unsure whether your treatment is working, or if you have a family history and have never had a full nerve assessment, a second opinion is always appropriate. Early course correction protects what cannot be recovered.

📍 Dr Shibal Bhartiya — Marengo Asia Hospitals, Gurugram

📞 +91 88826 38735 | 🌐 www.drshibalbhartiya.com


About the Author

This article was written by Dr Shibal Bhartiya, fellowship-trained glaucoma specialist and Mayo Clinic Research Collaborator, Clinical Director at Marengo Asia Hospitals, Gurugram, known for ethical, patient-centred glaucoma care and independent glaucoma second opinions. She is also the Program Director for Community Outreach & Wellness; and for the Marengo Asia International Institute of Neuro and Spine.

She has published peer-reviewed research on glaucoma management, examining how treatment decisions should balance medical evidence, patient preferences, and long-term vision outcomes.

As Editor-in-Chief of Clinical and Experimental Vision and Eye Research and Executive Editor of the Journal of Current Glaucoma Practice (Pubmed Indexed, official journal of the International Society of Glaucoma Surgery), Dr Shibal Bhartiya brings editorial and research depth to every clinical decision. Her 200+ publications, including 90+ PubMed-indexed publications and 28 edited textbooks span glaucoma biology, surgical outcomes, health equity, and emerging diagnostics.

Access her work on PubmedGoogle ScholarResearchGate and ORCID.

Dr Shibal Bhartiya
Glaucoma • Second Opinion • Advanced Care

www.drshibalbhartiya.com
 +91 88826 38735

1500+ Five Star Patient Reviews Google Business Profile

Upload your reports for a structured review.

If you are unable to come to Dr Bhartiya’s clinic: Read more about teleconsultation for glaucoma

Related Reading

Get an Online Glaucoma Consult

Visual Field and OCT: Structure & Function Correlation

Glaucoma Diagnosis in Gurgaon

Risk Stratification in Glaucoma

Glaucoma Progression: What It Means and How to Slow It

Glaucoma treatment in Gurgaon

All About Glaucoma Medication

Glaucoma Lasers: SLT & LPI

Glaucoma surgery in Gurgaon

MIGS in Gurgaon

Get a Glaucoma Second Opinion in Gurgaon